About Cure Alzheimer's Fund

Headquartered in Wellesley, MA, the Cure Alzheimer’s Fund team is comprised of mission-driven professionals who share a commitment to finding a cure. The Board of Directors, Trustees, and select donors support all operating expenses, allowing every general dollar raised to go directly to support research initiatives. With 30 full and part-time staff and more than 827 grants funded around the world, Cure Alzheimer’s Fund has distributed nearly $200,000,000 to Alzheimer’s research, with many projects resulting in breakthroughs that afford a deeper understanding of Alzheimer’s disease to get closer to a cure. There are currently 6 million people in the United States and 50 million worldwide who have been diagnosed with Alzheimer’s disease. Current estimates are that this represents 25% of the actual number of those afflicted; the others have not yet been diagnosed. Underrepresented racial groups and women are most at risk. Of those who have the disease, two-thirds are women. Black persons are twice as likely to get the disease as white persons, and the rate of the disease within the Hispanic and Latino populations is expected to grow 7x in the next 30 years. Recognizing that therapies are only possible when based on successful foundational research, founding board directors Henry McCance, Jeffrey and Jacqueline Morby, and Phyllis Rappaport formed Cure Alzheimer’s Fund in 2004 with an unwavering focus on providing research grants to the world’s leading scientists researching Alzheimer’s disease. The organization’s vision has been carefully and ambitiously designed to accelerate research, make bold bets, and eradicate Alzheimer’s disease.

Learn more by visiting www.curealz.org.